BackLifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Overview

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Total Assets

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's total assets is $70M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$70.12M
4.74% YoYΔ $-3.49M vs prior year quarter

Peer average

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Total Assets History

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A vs. peers: Total Assets Comparison

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A (LFMDP) FAQ

As of the most recent data (March 2026), LFMDP shows a total assets of $70M. That compares with $74M in the prior-year period — down 4.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LFMDP's total assets is now $70M (was $74M) — a 4.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.

Tracking LFMDP's total assets over time shows whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $70M That compares with $74M in the prior-year period — down 4.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $70M) with ownership activity and broader fundamentals.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's total assets is $70M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.